Next Article in Journal
Reassessment of Gene-Elusive Familial Dilated Cardiomyopathy Leading to the Discovery of a Homozygous AARS2 Variant—The Importance of Regular Reassessment of Genetic Findings
Previous Article in Journal
Biventricular Strain Imaging with Cardiac MRI in Genotyped and Histology Validated Amyloid Cardiomyopathy

Cardiac Amyloidosis: Diagnostic Tools for a Challenging Disease

Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy
Author to whom correspondence should be addressed.
Academic Editor: Juan Ramon Gimeno
Cardiogenetics 2021, 11(3), 111-121;
Received: 7 January 2021 / Revised: 23 June 2021 / Accepted: 27 June 2021 / Published: 23 July 2021
Amyloidosis is a group of diseases in which amyloid fibrils build up in tissues, leading to organ dysfunction. Cardiac involvement is observed in immunoglobulin light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) and, when it occurs, the prognosis worsens. Cardiac tissue infiltration can lead to restrictive cardiomyopathy with clinical signs of diastolic heart failure, without reduction of ejection fraction (HFpEF). The aim of multiple and less invasive diagnostic tests is to discern peculiar characteristics and reach the diagnosis without performing an invasive endomyocardial biopsy. These diagnostic tools allow early diagnosis, and they are crucial to best benefit from target therapy. In this review article, we describe the mechanism behind amyloid fibril formation, infiltration of tissues, and consequent clinical signs, focusing on the diagnostic tools and the red flags to obtain a diagnosis. View Full-Text
Keywords: cardiac amyloidosis; amyloidosis diagnosis cardiac amyloidosis; amyloidosis diagnosis
Show Figures

Figure 1

MDPI and ACS Style

Migliaccio, M.G.; Iodice, F.; Di Mauro, M.; Iannuzzi, A.; Pacileo, R.; Caiazza, M.; Esposito, A. Cardiac Amyloidosis: Diagnostic Tools for a Challenging Disease. Cardiogenetics 2021, 11, 111-121.

AMA Style

Migliaccio MG, Iodice F, Di Mauro M, Iannuzzi A, Pacileo R, Caiazza M, Esposito A. Cardiac Amyloidosis: Diagnostic Tools for a Challenging Disease. Cardiogenetics. 2021; 11(3):111-121.

Chicago/Turabian Style

Migliaccio, Marco G., Franco Iodice, Marco Di Mauro, Angela Iannuzzi, Roberta Pacileo, Martina Caiazza, and Augusto Esposito. 2021. "Cardiac Amyloidosis: Diagnostic Tools for a Challenging Disease" Cardiogenetics 11, no. 3: 111-121.

Find Other Styles

Article Access Map by Country/Region

Back to TopTop